Prescription Digital Therapeutic for Anxiety, Depression Treatment Launched
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
General Psychiatry
Azstarys, a Novel ADHD Treatment, Now Available
Azstarys consists of serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate.
Alcohol Withdrawal: Individualized Care and Pharmacologic Treatment
More than 50% of patients with alcohol use disorder develop alcohol withdrawal symptoms within hours of discontinuing or decreasing alcohol use.
What Does the Future of the Mental Health Pandemic Hold?
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
Multispecialty Perspectives on Long COVID-19
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Addressing Sleep Disturbances of Parkinson Disease
Sleep disturbances may affect 40% to 90% of patients with PD, and a 2020 study found that about half of patients with PD had multiple sleep disorders.
Lybalvi Approved for Schizophrenia, Bipolar I Disorder
The approval was based on data from 27 clinical studies, including the phase 3 ENLIGHTEN-1 and ENLIGHTEN-2 studies.
Clues to Memory Impairment in Cerebral Amyloid Angiopathy
The researchers’ objective was to assess the neuroimaging features of patients with cerebral amyloid angiopathy, or CAA, with and without objective memory impairment using tau PET imaging.
Qelbree Now Available for Pediatric ADHD
Qelbree is a selective norepinephrine reuptake inhibitor.
Novel Glycine Transporter Inhibitor Gets Breakthrough Tx Status for Cognitive Impairment With Schizophrenia
The designation is based on results from a phase 2 trial that evaluated the efficacy and safety of 4 different doses of BI 425809 orally once daily in adults with CIAS for 12 weeks.
- Loading...
Loading...
Next post in News
Loading... 
Loading...